Video Experimental Relacionado
Updated: Jan 29, 2026
10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
26.5K
Uso del programa de pago por rendimiento para reducir el riesgo de sarcopenia: un estudio anidado de casos y
Hui-Ju Huang1, Pin-Fan Chen2,3, Chieh-Tsung Yen4
1Department of Nursing, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi 62247, Taiwan.
Medicina (Kaunas, Lithuania)
|January 28, 2026
Resumen
La participación en el programa de pago por rendimiento (P4P) se asoció con una reducción del riesgo de sarcopenia en pacientes con diabetes mellitus tipo 2 (DM2). La participación temprana e intensiva en P4P redujo aún más este riesgo, lo que sugiere su valor en la atención de la DM2.
Área de la Ciencia:
- Endocrinología; Geriatría; Salud Pública
Sus antecedentes:
- El manejo de la diabetes mellitus tipo 2 (DM2) ha avanzado, sin embargo, la sarcopenia sigue siendo una complicación importante.; El pago por rendimiento (P4P) es una estrategia de mejora de la calidad con investigación limitada sobre su impacto en la prevención de la sarcopenia.; La sarcopenia representa un desafío creciente para la atención médica a nivel mundial, particularmente en poblaciones diabéticas.
Objetivo del estudio:
- Investigar la asociación entre la participación en programas P4P y el riesgo de desarrollar sarcopenia en pacientes con DM2.; Evaluar el impacto de P4P en la prevención de la sarcopenia dentro de una gran cohorte de personas con DM2.
Principales métodos:
- Se utilizó un estudio anidado de casos y controles utilizando un gran conjunto de datos de reclamaciones taiwanésas (2001-2013).; Se realizó un seguimiento de personas de 20 a 70 años con diagnóstico reciente de DM2 para detectar la aparición de sarcopenia.; Se empleó un análisis de regresión logística condicional para determinar la razón de momios ajustada (aOR) del riesgo de sarcopenia asociada con la participación en P4P.
Principales resultados:
- El estudio incluyó 3475 casos de sarcopenia y 6948 controles emparejados.; Los participantes del programa P4P exhibieron un riesgo significativamente menor de sarcopenia (aOR = 0.66; IC del 95%: 0.61-0.74).; La inscripción temprana (dentro de 1 año del diagnóstico de DM2) y la participación de mayor intensidad en P4P se correlacionaron con una mayor reducción del riesgo.
Conclusiones:
- La integración de P4P en la atención estándar de la DM2 puede ser una estrategia eficaz para la prevención de la sarcopenia.; Los hallazgos subrayan los beneficios potenciales de la colaboración interdisciplinaria y la implementación oportuna de los programas P4P.; P4P demuestra ser prometedor en la mitigación de una complicación clave de la diabetes mellitus tipo 2.
Videos de Conceptos Relacionados
01:22Diabetes Mellitus: Type 2 and Gestational
4.7K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.7K
01:22Diabetes Mellitus: Overview and Type I Subtype
5.2K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.2K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
427
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
427
01:25Glycolysis: Pay-off Phase
12.2K
So far, glycolysis has cost the cell two ATP molecules and produced two small, three-carbon sugar molecules. These molecules will proceed through the second half of the pathway, and sufficient energy will be extracted to pay back the two ATP molecules used as an initial investment and produce a profit for the cell of two additional ATP molecules and two even higher-energy NADH molecules.
Step 1 - 5: Glycolysis Preparatory Phase
The first phase of glycolysis has 5 steps where the glucose is...
Step 1 - 5: Glycolysis Preparatory Phase
The first phase of glycolysis has 5 steps where the glucose is...
12.2K
01:15High-Performance Liquid Chromatography: Types of Detectors
1.7K
The role of the detectors in High-Performance Liquid Chromatography (HPLC) is to analyze the solutes as they exit from the chromatographic column. The detector recognizes the solute's property and generates corresponding electrical signals, which are converted into a readable graph of the detector's response versus elution time called a chromatogram at the computer. There are several types of HPLC detectors, each with its own advantages and limitations, depending on the analyte...
1.7K
01:12Relative Risk
2.1K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.1K